Directed new share issue in Medivir AB (SE) — SEK 281 million

Carnegie acted as joint lead manager and book-runner in the directed new share issue of 2.25 million new class B shares at a price of SEK 125 per share. Medivir is an emerging research-based specialty pharmaceutical company focused on the development of high-value treatments for infectious diseasesDecember, 2010.